These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11995778)

  • 1. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women.
    Rasgon NL; Altshuler LL; Fairbanks LA; Dunkin JJ; Davtyan C; Elman S; Rapkin AJ
    J Clin Psychiatry; 2002; 63 Suppl 7():45-8. PubMed ID: 11995778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine efficacy in menopausal women with and without estrogen replacement.
    Amsterdam J; Garcia-España F; Fawcett J; Quitkin F; Reimherr F; Rosenbaum J; Beasley C
    J Affect Disord; 1999 Sep; 55(1):11-7. PubMed ID: 10512601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.
    Cohen LS; Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL
    Am J Psychiatry; 2003 Aug; 160(8):1519-22. PubMed ID: 12900318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group.
    Schneider LS; Small GW; Hamilton SH; Bystritsky A; Nemeroff CB; Meyers BS
    Am J Geriatr Psychiatry; 1997; 5(2):97-106. PubMed ID: 9106373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
    Soares CN; Almeida OP; Joffe H; Cohen LS
    Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does estrogen enhance the antidepressant effects of fluoxetine?
    Westlund Tam L; Parry BL
    J Affect Disord; 2003 Oct; 77(1):87-92. PubMed ID: 14550939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
    Iosifescu DV; Nierenberg AA; Mischoulon D; Perlis RH; Papakostas GI; Ryan JL; Alpert JE; Fava M
    J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH; Salinas E
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.
    Simpson GM; El Sheshai A; Rady A; Kingsbury SJ; Fayek M
    J Clin Psychiatry; 2003 Aug; 64(8):959-65. PubMed ID: 12927014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
    Levitt AJ; Joffe RT; Kamil R; McIntyre R
    J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression.
    Karaoulanis SE; Rizouli KA; Rizoulis AA; Angelopoulos NV
    BMC Psychiatry; 2014 Jun; 14():164. PubMed ID: 24894416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual symptoms in depressed patients who respond acutely to fluoxetine.
    Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
    Ladd CO; Newport DJ; Ragan KA; Loughhead A; Stowe ZN
    Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
    Schmidt ME; Fava M; Robinson JM; Judge R
    J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.